查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
甲真菌病全球市场规模调查和预测按类型（远端甲真菌病,浅表白色甲真菌病,近端甲真菌病,其他）,治疗方法（口服,甲真菌病,局部,其他）区域分析2022-2029
市场调查报告书
商品编码
1251571

甲真菌病全球市场规模调查和预测按类型（远端甲真菌病,浅表白色甲真菌病,近端甲真菌病,其他）,治疗方法（口服,甲真菌病,局部,其他）区域分析2022-2029

Global Onychomycosis Market Size study & Forecast, by Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Other Types) by Treatment (Oral, Topical, Others) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球甲真菌病市场价值约为 33 亿美元，预计在 2022-2029 年预测期内将以超过 4.56% 的健康增长率增长。

甲癣是一种指甲真菌感染。 它可能由皮肤癣菌或非皮肤癣菌霉菌引起。 症状始于指甲及其周围皮肤的物理变化。 指甲和组织经常变白或变黄，指甲可能变厚,变脆,变脆。 如果不加以控制，这些疾病的身体问题可能会变得更糟，并导致疼痛和炎症。 甲真菌病感染高发,新药研发投资增加,人口老龄化加剧,慢性病发病率上升以及抗真菌药物容易获得等因素推动了市场增长。

根据美国国家医学图书馆的数据，甲癣影响了全世界 10% 的人。 主要传染性真菌推测为红色毛癣菌。 此外，真菌和皮肤癣菌是非皮肤真菌，也是引起甲癣的原因。 在 98% 的感染中发现了红色毛癣菌。 此外，2019 年製药行业的研发支出达到 830 亿美元。 2010 年至 2019 年，美国食品药品监督管理局 (FDA) 平均批准了 38 种新药，比过去十年的年平均水平高出 60%。 甲癣感染的增加,研发投入的增加和新药开发是推动市场扩张的主要因素。 此外，老龄化社会,慢性病增加,抗真菌药物的可及性也是支撑市场扩张的重要因素。 此外，对甲癣治疗的认识不断提高和糖尿病患者人数的增加是在预测期内创造重要市场机会的因素。 然而，对甲癣感染的认识不足阻碍了整个 2022-2029 年预测期内的市场增长。

全球甲癣市场研究考虑的主要区域是亚太地区,北美,欧洲,拉丁美洲和世界其他地区。 由于甲癣感染率上升,医疗保健支出增加,对甲癣药物的认识提高以及政府加大研发力度，北美在收入方面占据了市场主导地位。我来了。 由于甲癣发病率较高,老年人口增加,城市化进程加快以及大公司对研发投资的关注等因素，预计亚太地区在预测期内将以最高复合年增长率增长。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 2019-2029 年按地区划分的甲癣市场
    • 2019-2029 年按类型划分的甲癣市场
    • 2019-2029 年甲癣市场，按治疗方式
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章甲癣全球市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第 3 章甲真菌病的全球市场动态

  • 甲癣市场影响分析 (2019-2029)
    • 市场驱动因素
      • 甲真菌感染的高流行率
      • 加大对新药研发的投入
    • 市场挑战
      • 缺乏对甲癣感染的认识
    • 市场机会
      • 提高对甲癣治疗的认识
      • 糖尿病患者增加

第 4 章甲癣全球市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 投资招聘模式
  • 分析师的建议和结论
  • 最佳投资机会
  • 关键成功策略

第 5 章风险评估 COVID-19 影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球甲癣市场：按类型

  • 市场概况
  • 全球甲癣市场：按类型,按性能 - 潜力分析
  • 2019-2029 年按类型分列的甲癣全球市场估计和预测
  • 甲癣市场,细分市场分析
    • 远端甲下甲癣
    • 浅表白色甲癣
    • 近端甲下甲癣
    • 其他类型

第 7 章全球甲癣市场，按治疗

  • 市场概况
  • 甲癣全球市场：按治疗,按表现 - 潜力分析
  • 2019-2029 年甲癣全球市场估计和治疗预测
  • 甲癣市场,细分市场分析
    • 口语
    • 本地
    • 其他

第 8 章全球甲癣市场：区域分析

  • 甲癣市场，按地区划分的市场概况
  • 北美
    • 美国
      • 按类型估算和预测，2019-2029 年
      • 2019-2029 年各治疗方法的估计和预测
    • 加拿大
  • 欧洲甲癣市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太地区甲癣市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲甲癣市场概况
    • 巴西
    • 墨西哥
  • 世界其他地方

第 9 章衝突信息

  • 顶级市场策略
  • 公司简介
    • Bausch Health Companies Inc.
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 产品概述
      • 近期趋势
    • Gsk Plc
    • Abbott
    • Pfizer Inc.
    • Bayer Ag
    • Teva Pharmaceutical Industries, Ltd.
    • Cipla Inc.
    • Novartis Ag
    • Sun Pharmaceutical Industries Ltd.
    • Merck & Co., Inc.

第 10 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

Global Onychomycosis Market is valued at approximately USD 3.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.56% over the forecast period 2022-2029. Onychomycosis is a fungal infection of the nails, and can also be referred to as dermatophytic onychomycosis. This can be a cause of dermatophytes and nondermatophytic molds. The symptoms begin with physical alterations to the nail and surrounding skin. The nail and tissue frequently turn white or yellow, and the nails might thicken and become brittle, making them more likely to break. Physical problems in this condition might deteriorate noticeably and cause pain and inflammation if not managed. The high prevalence of Onychomycosis infections, increasing investments in the R&D of novel drugs, increasing ageing population, rising incidence of chronic diseases, and easy accessibility of antifungal drugs are the factors driving the growth of the market.

According to the National Library of Medicine, there is 10% of the Onychomycosis infected population across the globe. Trichophyton rubrum was estimated to be the main infecting organism. Nondermatophyte mould and dermatophytes are the other causes of Onychomycosis infections. T. rubrum organisms were found in 98% of the infections. Additionally, The R&D expenditure in the pharmaceutical industry amounted to 83 billion dollars in 2019. Between 2010 and 2019, the Food and Drug Administration (FDA) approved 38 new medications on average, which is 60% more than it did on an annual average over the preceding ten years. Increasing Onychomycosis infections and increasing R&D investments and development of new drugs are the major factors driving the market growth. Other important components driving market increase are the increasing ageing population, rising incidence of chronic diseases, and easy accessibility of antifungal drugs. Furthermore, rising awareness about the treatment of Onychomycosis and the growing Diabetic Population are the factors creating major market opportunities in the forecast period. However, the lack of awareness of onychomycosis infections stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Onychomycosis Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of Onychomycosis infections, increasing healthcare expenditures, increase in the awareness of Onychomycosis drugs, and increasing government initiatives in R&D. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as high incidence of Onychomycosis infections, a growing geriatric population, increasing urbanization and focus of key players on investing in R&D.

Major market players included in this report are:

  • Bausch Health Companies Inc.
  • Gsk Plc
  • Abbott
  • Pfizer Inc.
  • Bayer Ag
  • Teva Pharmaceutical Industries, Ltd.
  • Cipla Inc.
  • Novartis Ag
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.

Recent Developments in the Market:

  • In March 2021, The Tianjin Institute of Pharmaceutical Research and HUYABIO International joint venture, submitted a new drug application efinaconazole, as Jublia™ for the treatment of onychomycosis.
  • In July 2021, Kaken Pharmaceutical (KKPCF) and Almirall S.A., a global biopharmaceutical company specializing in skin health, announced that they have signed a license and distribution agreement under which Kaken Pharmaceutical gives Almirall the exclusive right to develop and market the topical formulation of efinaconazole in Europe.

Global Onychomycosis Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Type, Treatment, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Distal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Proximal Subungual Onychomycosis
  • Other Types

By Treatment:

  • Oral
  • Topical
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Onychomycosis Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Onychomycosis Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Onychomycosis Market, by Treatment, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Onychomycosis Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Onychomycosis Market Dynamics

  • 3.1. Onychomycosis Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. High prevalence of Onychomycosis infections
      • 3.1.1.2. Increasing investments in the R&D of novel drugs
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of awareness of onychomycosis infections
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising awareness about the treatment of Onychomycosis
      • 3.1.3.2. Growing Diabetic Population

Chapter 4. Global Onychomycosis Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Onychomycosis Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Onychomycosis Market by Type, Performance - Potential Analysis
  • 6.3. Global Onychomycosis Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Onychomycosis Market, Sub Segment Analysis
    • 6.4.1. Distal Subungual Onychomycosis
    • 6.4.2. White Superficial Onychomycosis
    • 6.4.3. Proximal Subungual Onychomycosis
    • 6.4.4. Other Types

Chapter 7. Global Onychomycosis Market, by Treatment

  • 7.1. Market Snapshot
  • 7.2. Global Onychomycosis Market by Treatment, Performance - Potential Analysis
  • 7.3. Global Onychomycosis Market Estimates & Forecasts by Treatment 2019-2029 (USD Billion)
  • 7.4. Onychomycosis Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Topical
    • 7.4.3. Others

Chapter 8. Global Onychomycosis Market, Regional Analysis

  • 8.1. Onychomycosis Market, Regional Market Snapshot
  • 8.2. North America Onychomycosis Market
    • 8.2.1. U.S. Onychomycosis Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Treatment breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Onychomycosis Market
  • 8.3. Europe Onychomycosis Market Snapshot
    • 8.3.1. U.K. Onychomycosis Market
    • 8.3.2. Germany Onychomycosis Market
    • 8.3.3. France Onychomycosis Market
    • 8.3.4. Spain Onychomycosis Market
    • 8.3.5. Italy Onychomycosis Market
    • 8.3.6. Rest of Europe Onychomycosis Market
  • 8.4. Asia-Pacific Onychomycosis Market Snapshot
    • 8.4.1. China Onychomycosis Market
    • 8.4.2. India Onychomycosis Market
    • 8.4.3. Japan Onychomycosis Market
    • 8.4.4. Australia Onychomycosis Market
    • 8.4.5. South Korea Onychomycosis Market
    • 8.4.6. Rest of Asia Pacific Onychomycosis Market
  • 8.5. Latin America Onychomycosis Market Snapshot
    • 8.5.1. Brazil Onychomycosis Market
    • 8.5.2. Mexico Onychomycosis Market
  • 8.6. Rest of The World Onychomycosis Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Bausch Health Companies Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Gsk Plc
    • 9.2.3. Abbott
    • 9.2.4. Pfizer Inc.
    • 9.2.5. Bayer Ag
    • 9.2.6. Teva Pharmaceutical Industries, Ltd.
    • 9.2.7. Cipla Inc.
    • 9.2.8. Novartis Ag
    • 9.2.9. Sun Pharmaceutical Industries Ltd.
    • 9.2.10. Merck & Co., Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Onychomycosis Market, report scope
  • TABLE 2. Global Onychomycosis Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Onychomycosis Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Onychomycosis Market estimates & forecasts by Treatment 2019-2029 (USD Billion)
  • TABLE 5. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Onychomycosis Market
  • TABLE 70. List of primary sources, used in the study of global Onychomycosis Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Onychomycosis Market, research methodology
  • FIG 2. Global Onychomycosis Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Onychomycosis Market, key trends 2021
  • FIG 5. Global Onychomycosis Market, growth prospects 2022-2029
  • FIG 6. Global Onychomycosis Market, porters 5 force model
  • FIG 7. Global Onychomycosis Market, pest analysis
  • FIG 8. Global Onychomycosis Market, value chain analysis
  • FIG 9. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Onychomycosis Market, regional snapshot 2019 & 2029
  • FIG 15. North America Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Onychomycosis Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable